MyFinsight
Home
About
Contact
regn: the income statement
Download
Download image
Non Us
$146,100K
(55.26%↑ Y/Y)
US
$219,100K
(12.65%↑ Y/Y)
Eylea Net Product
Sales
$680,600K
(-40.54%↓ Y/Y)
ELYEAHD
$430,600K
(9.76%↑ Y/Y)
Other Products
$800K
Evkeeza-US
$42,800K
(32.10%↑ Y/Y)
Praluent Net Product
Sales-US
$67,700K
(27.98%↑ Y/Y)
LIBTAYONet Product Sales
$365,200K
(26.54%↑ Y/Y)
ELYEAHDAnd EYLEA-US
$1,111,200K
(-27.70%↓ Y/Y)
Product And Service
Other
$198,200K
(73.56%↑ Y/Y)
Collaboration Revenue
$1,968,400K
(18.57%↑ Y/Y)
Product
$1,587,700K
(-18.43%↓ Y/Y)
Other income
(expense), net
$755,800K
(130.92%↑ Y/Y)
Revenues
$3,754,300K
(0.90%↑ Y/Y)
Total other income
(expense)
$736,500K
(134.93%↑ Y/Y)
Income from operations
$1,026,800K
(-12.95%↓ Y/Y)
Interest expense
$19,300K
(39.86%↑ Y/Y)
Total expenses
$2,727,500K
(7.33%↑ Y/Y)
Other operating
(income) expense, net
$10,000K
(225.00%↑ Y/Y)
Income before income
taxes
$1,763,300K
(18.10%↑ Y/Y)
Cost of goods sold,
collaboration and contract...
$240,600K
(5.16%↑ Y/Y)
Cost of goods sold,
collaboration and contract...
$281,000K
(7.13%↑ Y/Y)
Selling, general, and
administrative
$657,800K
(-7.92%↓ Y/Y)
Acquired in-process
research and development
$83,100K
(47.86%↑ Y/Y)
Research and development
$1,475,000K
(16.00%↑ Y/Y)
Gain on foreign
currency translation
$800K
(-57.89%↓ Y/Y)
Unrealized gain on debt
securities
$15,700K
(-87.75%↓ Y/Y)
Net income
$1,460,000K
(8.91%↑ Y/Y)
Income tax expense
$303,300K
(99.02%↑ Y/Y)
Comprehensive income
$1,476,500K
(0.39%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)